Biotechnology Portfolio Biotechnology Fund Probability of Future Mutual Fund Price Finishing Over 20.86
| FBIOX Fund | USD 19.74 0.69 3.38% |
Biotechnology |
Biotechnology Portfolio Target Price Odds to finish over 20.86
The tendency of Biotechnology Mutual Fund price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over $ 20.86 or more in 90 days |
| 19.74 | 90 days | 20.86 | about 65.43 |
Based on a normal probability distribution, the odds of Biotechnology Portfolio to move over $ 20.86 or more in 90 days from now is about 65.43 (This Biotechnology Portfolio Biotechnology probability density function shows the probability of Biotechnology Mutual Fund to fall within a particular range of prices over 90 days) . Probability of Biotechnology Portfolio price to stay between its current price of $ 19.74 and $ 20.86 at the end of the 90-day period is about 33.08 .
Assuming the 90 days horizon Biotechnology Portfolio has a beta of 0.35. This usually indicates as returns on the market go up, Biotechnology Portfolio average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Biotechnology Portfolio Biotechnology will be expected to be much smaller as well. Additionally Biotechnology Portfolio Biotechnology has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Biotechnology Portfolio Price Density |
| Price |
Predictive Modules for Biotechnology Portfolio
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Biotechnology Portfolio. Regardless of method or technology, however, to accurately forecast the mutual fund market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the mutual fund market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Biotechnology Portfolio Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Biotechnology Portfolio is not an exception. The market had few large corrections towards the Biotechnology Portfolio's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Biotechnology Portfolio Biotechnology, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Biotechnology Portfolio within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.14 | |
β | Beta against Dow Jones | 0.35 | |
σ | Overall volatility | 0.63 | |
Ir | Information ratio | -0.15 |
Biotechnology Portfolio Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Biotechnology Portfolio for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Biotechnology Portfolio can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Biotechnology Portfolio generated a negative expected return over the last 90 days | |
| The fund retains 96.05% of its assets under management (AUM) in equities |
Biotechnology Portfolio Technical Analysis
Biotechnology Portfolio's future price can be derived by breaking down and analyzing its technical indicators over time. Biotechnology Mutual Fund technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Biotechnology Portfolio Biotechnology. In general, you should focus on analyzing Biotechnology Mutual Fund price patterns and their correlations with different microeconomic environments and drivers.
Biotechnology Portfolio Predictive Forecast Models
Biotechnology Portfolio's time-series forecasting models is one of many Biotechnology Portfolio's mutual fund analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Biotechnology Portfolio's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the mutual fund market movement and maximize returns from investment trading.
Things to note about Biotechnology Portfolio
Checking the ongoing alerts about Biotechnology Portfolio for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Biotechnology Portfolio help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Biotechnology Portfolio generated a negative expected return over the last 90 days | |
| The fund retains 96.05% of its assets under management (AUM) in equities |
Other Information on Investing in Biotechnology Mutual Fund
Biotechnology Portfolio financial ratios help investors to determine whether Biotechnology Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Biotechnology with respect to the benefits of owning Biotechnology Portfolio security.
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |